Drug Testing Locations - Bladensburg, MD

Drug Testing in Bladensburg, MD

Bladensburg, Maryland Statistics

In Bladensburg, MD, located in Prince George's County, opioid overdose deaths increased by 13% in 2021.

The number of drug-related emergency room visits in Prince George's County, including Bladensburg, rose by 8% in 2020.

Bladensburg, MD, saw a 15% increase in drug-related arrests in Prince George's County in 2019.

In 2021, Bladensburg reported a 20% increase in youth drug use cases compared to the previous year in Prince George's County.

Prince George's County health reports indicated that Bladensburg was a hotspot for synthetic drug activity in 2019.

The Prince George’s County health department in Bladensburg noted a 10% increase in addiction treatment admissions in 2022.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Bladensburg, MD & Drug Testing Policies

Employers in Bladensburg, MD, recognize the importance of maintaining a drug-free workplace, which has led to the adoption of rigorous drug testing policies. Companies often implement pre-employment screenings and random drug tests to ensure safety and productivity. These measures are in line with guidelines provided by the U.S. Department of Labor.

Larger employers particularly enforce strict zero-tolerance policies as part of their commitment to workplace safety. This includes conducting regular training sessions and educational programs on substance abuse. Moreover, Bladensburg businesses collaborate with local health departments to provide support for employees struggling with addiction, ensuring access to treatment and counseling services.

The Maryland Department of Labor offers resources and guidance for employers in implementing effective drug testing policies. These policies not only minimize the potential for on-site accidents but also enhance overall job performance and employee well-being in Bladensburg.

Government Efforts with Drug Problems in Bladensburg, MD

The government of Bladensburg, MD, is actively engaged in tackling the persistent drug issues within the community. Programs like the Behavioral Health Integration Initiative aim to enhance support and resources for individuals struggling with addiction. The local government collaborates with Prince George's County to improve access to mental health services, ensuring residents receive comprehensive care. More details can be found at the Prince George's County Substance Abuse webpage.

Statewide initiatives also play a crucial role, with the Maryland Department of Health allocating funds specifically for drug prevention and treatment programs. By partnering with local nonprofits, schools, and law enforcement, the state strives to create awareness and reduce the stigma associated with addiction. To explore more about these efforts, visit the Maryland Behavioral Health Administration website.

Local Drug Busts & News in Bladensburg, MD

In recent years, Bladensburg, MD, has witnessed a series of drug busts that have underscored the ongoing challenges faced by law enforcement in tackling illegal substance distribution. These operations have often been the result of lengthy investigations, highlighting collaborative efforts among local police and federal agencies. The seizures involved significant quantities of narcotics, aiming to disrupt the supply chains affecting the community.

One notable operation took place near the historic district of Bladensburg, where authorities uncovered a sophisticated drug trafficking ring. This bust was a critical success for the local police, as it not only led to multiple arrests but also resulted in the confiscation of firearms and cash. The event underscored the heightened vigilance required to combat the clandestine drug activity in the region.

Community leaders in Bladensburg have called for increased awareness and preventive measures to address the root causes of such drug-related activities. Educational programs and outreach initiatives are being proposed to steer younger residents away from involvement with drugs. By partnering with local schools, police hope to educate students on the severe consequences of drug abuse and trafficking.

Bladensburg's proximity to major highways has made it a strategic area for drug distribution, necessitating continuous monitoring and strategic interventions. Law enforcement agencies remain committed to employing advanced technology and methods to anticipate and prevent further illicit activities. These efforts are essential to safeguarding the town's residents and maintaining public safety.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Bladensburg, MD. Trusted by employers nationwide for accurate results and exceptional service.

Maryland DOT/Non DOT Physicals

Maryland Vision Tests

Maryland Audiograms

Maryland Respirator Fit Tests

Maryland Lift Tests

Maryland Background Checks

Clinical Testing Services

TB Testing in MD

Diabetes Testing in MD

Infectious Disease Testing in MD

Sickle Cell Anemia Testing in MD

Women/Men's Health Testing in MD

Resources & Citations

Maryland Department of Health MERLIN

Maryland House of Delegates

Johns Hopkins Substance Use Disorders

A Better Way Counseling

University of Maryland Medical Center

SHRM Maryland Updates

Prince George's County Government

Maryland Behavioral Health

Maryland Addiction Recovery Center

Naomi Washington Project

Drug Testing Near Bladensburg, MD

Fairmount Heights, MD

Greater Landover, MD

Landover Hills, MD

University Park, MD

Landover, MD

East Riverdale, MD

Mount Rainier, MD

Riverdale Park, MD

Hyattsville, MD

Brentwood, MD

Cheverly, MD

North Brentwood, MD

Cottage City, MD

Colmar Manor, MD

Edmonston, MD

Frequently Asked Questions

Customer Reviews